SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.

SCCM Pod-331 Bleeding Management and Reversal Strategies for the DOAC Patient: New and Future Approa

visual bubble
visual bubble
12/1/2016

Todd Fraser, MD, speaks with Scott Kaatz, DO, FACP, SFHM, about his talk given at the 45th Critical Care Congress on, “Bleeding Management and Reversal Strategies for the DOAC Patient: New and Future Approaches.” Dr. Kaatz is Senior Staff Hospitalist and Medical Director for Professional Development and Research in the Division of Hospital Medicine at Henry Ford Hospital in Detroit, Michigan. He identified the following disclosures: speaker honorarium (Janssen, Boehringer-Ingelheim, Bristol Myer Squibb, Pfizer, CSL Behring, Daiichi Sankyo), consultancy (Boehringer Ingelheim, Bristol Myer Squibb, Pfizer, Janssen, Daiichi Sankyo, Portola), and board membership (Thrombosis and Hemostasis Societies of North America AC Forum, National Certification Board of Anticoagulation Providers, National Blood Clot Alliance Medical and Scientific Advisory Board).

*If you are unable to play the podcast please click here to download the file.

Category: Other

 

Disclaimer